Jia Jie Biomedical Co Ltd (4109) — Cash Flow Quality Index
Jia Jie Biomedical Co Ltd (4109) has a Cash Flow Quality Index of 0.41x as of December 2025. Operating cash flow of NT$11.32 Million is below net income of NT$27.33 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 4109 long-term investments to assets to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jia Jie Biomedical Co Ltd Cash Flow Quality Index (2015–2025)
Historical Cash Flow Quality Index for Jia Jie Biomedical Co Ltd across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 4109 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Jia Jie Biomedical Co Ltd (2015–2025)
Year-by-year earnings quality comparison for Jia Jie Biomedical Co Ltd. For live market cap and the full company financial profile, see 4109 market cap overview.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.42x | NT$21.34 Million | NT$50.26 Million | ▲ +102.4% |
| 2024 | 0.21x | NT$44.35 Million | NT$211.37 Million | ▲ +785.1% |
| 2023 | -0.03x | NT$-4.49 Million | NT$146.55 Million | ▼ -103.7% |
| 2021 | 0.83x | NT$4.37 Million | NT$5.29 Million | ▲ +115.6% |
| 2018 | -5.29x | NT$-13.10 Million | NT$2.47 Million | ▲ +19.6% |
| 2016 | -6.58x | NT$-76.54 Million | NT$11.63 Million | ▼ -402.9% |
| 2015 | 2.17x | NT$82.22 Million | NT$37.84 Million | — |